Sangamo Therapeutics, Inc. (SGMO)
0.4416
+0.01
(+2.70%)
USD |
NASDAQ |
Dec 24, 12:59
0.44
0.00 (0.00%)
After-Hours: 13:59
Sangamo Therapeutics SG&A Expense (TTM): 36.99M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 44.43M |
| AIM ImmunoTech, Inc. | 10.06M |
| Perspective Therapeutics, Inc. | 31.53M |
| Protalix Biotherapeutics, Inc. | 11.16M |
| Armata Pharmaceuticals, Inc. | 12.31M |